Table 5. Vaccine Procurement and Supply Agreement With COVAX .
Income - COVAX | AstraZeneca-Oxford | Janssen | Pfizer-BioNTtech | Moderna |
HICs | 965 400 (37%) | 352 000 (41%) | 239 6870 (79.0%) | 816 500 (62.0%) |
UMICs | 498 140 (19%) | 59 100 (8%) | 510 100 (17.0%) | 1050 (>0.1%) |
LMICs + LICs | 429 725 (17%) | 240 000 (28%) | 76 400 (2.5%) | 13 000 (>1.0%) |
COVAX | 721 000 (27%) | 200 000 (23%) | 40 000 (1.5%) | 500 000 (37.0%) |
Total | 2 614 265 (100%) | 851 100 (100%) | 3 023 370 (100%) | 1 330 550 (100%) |
Abbreviations: COVAX, COVID-19 Vaccine Global Access; HICs, High-income countries; UMICs, upper-middle-income countries; LMICs, low- and middle-income countries; LICs, low-income countries.